{
    "2018-07-10": [
        [
            {
                "time": "",
                "original_text": "视频丨郭广昌正式退出复星医药董事会",
                "features": {
                    "keywords": [
                        "郭广昌",
                        "退出",
                        "复星医药",
                        "董事会"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[看好评级]医药生物行业2018年中报业绩前瞻：医疗需求刚性 重点關注稳健成长和“流量入口”型公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2018年中报",
                        "医疗需求",
                        "稳健成长",
                        "流量入口"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "两大逻辑促疫苗股飙升 4只白马股备受机构青睐",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "飙升",
                        "白马股",
                        "机构青睐"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "郭广昌又卸任一家子公司职务：已退出复星医药董事会",
                "features": {
                    "keywords": [
                        "郭广昌",
                        "卸任",
                        "子公司",
                        "复星医药",
                        "董事会"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药确认郭广昌已退出公司董事会",
                "features": {
                    "keywords": [
                        "复星医药",
                        "确认",
                        "郭广昌",
                        "退出",
                        "董事会"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：布局政策免疫品种 推荐二线细分龙头",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "政策免疫",
                        "二线细分龙头"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "两大逻辑促疫苗股飙升 6只白马股备受机构青睐",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "飙升",
                        "白马股",
                        "机构青睐"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}